175 related articles for article (PubMed ID: 9453323)
1. Relationship between endothelial function and fibrinolysis in early hypertension.
Tomiyama H; Kimura Y; Mitsuhashi H; Kinouchi T; Yoshida H; Kushiro T; Doba N
Hypertension; 1998 Jan; 31(1 Pt 2):321-7. PubMed ID: 9453323
[TBL] [Abstract][Full Text] [Related]
2. Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients.
Fogari R; Preti P; Lazzari P; Corradi L; Zoppi A; Fogari E; Mugellini A
Eur J Clin Pharmacol; 2003 Aug; 59(4):271-5. PubMed ID: 12830340
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension.
Fogari R; Zoppi A; Salvadeo SA; Mugellini A; Lazzari P; Santoro T; Derosa G
Hypertens Res; 2011 Apr; 34(4):509-15. PubMed ID: 21179101
[TBL] [Abstract][Full Text] [Related]
4. Effects of lisinopril, irbesartan, and amlodipine on the thrombogenic variables in the early and late stages of the treatment in hypertensive patients.
Tiryaki O; Usalan C; Buyukhatipoglu H; Sayiner ZA; Kilisli H
Clin Exp Hypertens; 2012; 34(2):145-52. PubMed ID: 21967026
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition and fibrinolytic balance.
Matsumoto T; Horie M
Hypertens Res; 2011 Apr; 34(4):448-9. PubMed ID: 21326308
[No Abstract] [Full Text] [Related]
6. Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension.
Erdem Y; Usalan C; Haznedaroğlu IC; Altun B; Arici M; Yasavul U; Turgan C; Cağlar S
Am J Hypertens; 1999 Nov; 12(11 Pt 1):1071-6. PubMed ID: 10604482
[TBL] [Abstract][Full Text] [Related]
7. Triglycerides as an early pathophysiological marker of endothelial dysfunction in nondiabetic women with a previous history of gestational diabetes.
Sokup A; Góralczyk B; Góralczyk K; Rość D
Acta Obstet Gynecol Scand; 2012 Feb; 91(2):182-8. PubMed ID: 21954994
[TBL] [Abstract][Full Text] [Related]
8. Impaired fibrinolysis and insulin resistance in patients with hypertension.
Jeng JR; Sheu WH; Jeng CY; Huang SH; Shieh SM
Am J Hypertens; 1996 May; 9(5):484-90. PubMed ID: 8735180
[TBL] [Abstract][Full Text] [Related]
9. Close relationship of abnormal glucose tolerance with endothelial dysfunction in hypertension.
Tomiyama H; Kimura Y; Okazaki R; Kushiro T; Abe M; Kuwabara Y; Yoshida H; Kuwata S; Kinouchi T; Doba N
Hypertension; 2000 Aug; 36(2):245-9. PubMed ID: 10948085
[TBL] [Abstract][Full Text] [Related]
10. Endothelium-dependent vasodilation and tissue-type plasminogen activator release in borderline hypertension.
Jern S; Wall U; Bergbrant A; Selin-Sjögren L; Jern C
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3376-83. PubMed ID: 9437182
[TBL] [Abstract][Full Text] [Related]
11. Influence of baseline values on lipids, lipoproteins and fibrinolytic parameters during amlodipine treatment of hypertension in Japanese patients.
Ahaneku JE; Sakata K; Urano T; Takada Y; Takada A
Pharmacol Res; 2000 Jan; 41(1):75-9. PubMed ID: 10600272
[TBL] [Abstract][Full Text] [Related]
12. Effect of benazepril on endothelial function in previously untreated hypertensive patients. The Working Group of Cardiology of the Academic Committee of Veszprém, Hungary.
Nagy L; Tarján J; Sámóczi M; Kovács I; Takács J
Am J Ther; 1998 Jul; 5(4):233-6. PubMed ID: 10099064
[TBL] [Abstract][Full Text] [Related]
13. Coagulation and fibrinolytic parameters in patients with pulmonary hypertension.
Altman R; Scazziota A; Rouvier J; Gurfinkel E; Favaloro R; Perrone S; Fareed J
Clin Cardiol; 1996 Jul; 19(7):549-54. PubMed ID: 8818435
[TBL] [Abstract][Full Text] [Related]
14. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
[TBL] [Abstract][Full Text] [Related]
15. Effect of combined angiotensin-converting enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patients.
Tiryaki O; Usalan C; Buyukhatipoglu H
Nephrology (Carlton); 2010 Mar; 15(2):211-5. PubMed ID: 20470281
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women.
Fogari R; Zoppi A; Preti P; Fogari E; Malamani G; Mugellini A
Am J Hypertens; 2001 Sep; 14(9 Pt 1):921-6. PubMed ID: 11587159
[TBL] [Abstract][Full Text] [Related]
17. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
Gürlek A; Bayraktar M; Kirazli S
Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
[TBL] [Abstract][Full Text] [Related]
18. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.
Messerli FH; Oparil S; Feng Z
Am J Cardiol; 2000 Dec; 86(11):1182-7. PubMed ID: 11090788
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamic and metabolic effects of rilmenidine in hypertensive patients with metabolic syndrome X. A double-blind parallel study versus amlodipine.
De Luca N; Izzo R; Fontana D; Iovino G; Argenziano L; Vecchione C; Trimarco B
J Hypertens; 2000 Oct; 18(10):1515-22. PubMed ID: 11057441
[TBL] [Abstract][Full Text] [Related]
20. [Is the combination of benazepril and amlodipine more effective in hypertension than the combination of benazepril and hydrochlorothiazide? Results of the ACCOMPLISH trial].
Preobrazhenskiĭ DV
Kardiologiia; 2009; 49(2):81-2. PubMed ID: 19254225
[No Abstract] [Full Text] [Related]
[Next] [New Search]